Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three benznidazole tablet formulations in healthy adults
RBR-6zfzs4jPhase 1Completed
- Sponsor
- Scentryphar Pesquisa Clínica
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of benznidazole in American trypanosomiasis (CD) (3 arms), sponsored by Scentryphar Pesquisa Clínica. Started Oct 2022; status: completed.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on RBR-6zfzs4j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6zfzs4j.